Affordable Access

deepdyve-link
Publisher Website

Arterial chemoembolization for patients with hepatocellular carcinoma and elevated lactate dehydrogenase is associated with low survival: a cohort study.

Authors
  • Zhuang, Genghui1
  • Xie, Yuping2
  • Hong, Junfeng3
  • Lin, Shan4
  • Chen, Tingting1
  • Fang, Wenzheng5, 6, 7
  • 1 College of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, People's Republic of China. , (China)
  • 2 Department of Oncology, The 900th Hospital of Joint Logistic Support Force, PLA, Fuzong Clinical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China. , (China)
  • 3 Department of Ultrasound, The 900th Hospital of Joint Logistics Support Force, PLA, (Fuzhou General Hospital of Fujian Medical University, East Hospital Affiliated to Xiamen University), Fuzhou, Fujian, People's Republic of China. , (China)
  • 4 Department of Neurology, The 900th Hospital of Joint Logistic Support Force, PLA, Fuzong Clinical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China. , (China)
  • 5 College of Rehabilitation Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, People's Republic of China. [email protected] , (China)
  • 6 Department of Oncology, The 900th Hospital of Joint Logistic Support Force, PLA, Fuzong Clinical College of Fujian Medical University, Fuzhou, Fujian, People's Republic of China. [email protected] , (China)
  • 7 Fujian Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, People's Republic of China. [email protected] , (China)
Type
Published Article
Journal
Infectious Agents and Cancer
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Jun 16, 2022
Volume
17
Issue
1
Pages
31–31
Identifiers
DOI: 10.1186/s13027-022-00443-1
PMID: 35710505
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Serum lactate dehydrogenase (LDH) concentration has been used for the evaluation and prediction of prognosis of several tumors, including hepatocellular carcinoma (HCC). However, the relationship between changes in LDH after treatment (ΔLDH) and prognosis is still unclear. Herein, we aimed to determine this association in patients with HCC. Multivariate adjusted hazard ratios (HRs) and 95% confidence intervals (95% CIs) for HCC were obtained by Cox proportional hazard regression models. As for ΔLDH and overall survival (OS), the nonlinear relationship was evaluated through a restricted cubic spline regression analysis, and threshold effects were further calculated using a two-piece-wise Cox proportional hazard model. The study finally selected 749 patients with HCC treated by transarterial chemoembolization (TACE) for the secondary analysis. Considering the ΔLDH within ± 80 U/L group as the baseline, the risk of death in the ΔLDH ≥ 80 U/L group was significantly increased by 131% (95% CI: 1.74-3.06), and the risk of death in the ΔLDH ≤- 80 U/L group was increased by 24% (HR: 1.23, 95% CI: 0.99-1.55). However, this difference was not statistically significant. Furthermore, with ΔLDH = 0 (100 U/L) as the turning point, an upward U-shaped curve could be formed between ΔLDH and OS. After adjusting for confounders, ΔLDH still had a significant effect on the threshold of OS (P = 0.021). After TACE, with the increase of LDH index, HCC patients will be closely related to worse OS. © 2022. The Author(s).

Report this publication

Statistics

Seen <100 times